# A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus

> **NCT04655690** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 48 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** NNC0471-0119
- **DRUG:** Fast-acting insulin aspart

## Key facts

- **NCT ID:** NCT04655690
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-09
- **Primary completion:** 2021-11-26
- **Final completion:** 2021-11-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2023-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04655690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04655690, "A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04655690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*